hypertrophic cardiomyopathy |
Disease ID | 410 |
---|---|
Disease | hypertrophic cardiomyopathy |
Manually Symptom | UMLS | Name(Total Manually Symptoms:120) C2712322 | tachycardia C2700530 | fabry disease C2697420 | central core disease C2348362 | septal myocardial infarction C2215935 | complete heart block C2108112 | ventricular fibrillation C2063376 | diastolic mitral regurgitation C2041142 | left bundle branch block C1963244 | supraventricular tachycardia C1963220 | pulmonary hypertension C1963158 | left ventricular diastolic dysfunction C1962971 | myocarditis C1959583 | myocardial failure C1956346 | coronary artery disease C1956257 | pulmonary stenosis C1704212 | embolism C1550639 | fistula C1541923 | infective endocarditis C1521999 | acute myocardial infarction C1400513 | transmural myocardial infarction C1393529 | vascular complications C1388902 | asynergy C1313980 | ischemic heart disease C1135196 | diastolic heart failure C1090821 | sepsis C0948355 | myocardial bridging C0948355 | myocardial bridge C0948268 | hemodynamic instability C0856169 | endothelial dysfunction C0796095 | c syndrome C0750197 | sustained ventricular tachycardia C0750194 | non-sustained ventricular tachycardia C0746604 | mitral valve endocarditis C0741299 | atrial thrombus C0700361 | distress C0519097 | left ventricular aneurysm C0455683 | congenital heart disease C0432474 | klinefelter syndrome C0428811 | mitral annular calcification C0427008 | stiffness C0426768 | o sign C0392077 | cardiac sarcoidosis C0376293 | stigmata C0344955 | ventricular septal hypertrophy C0344431 | monomorphic ventricular tachycardia C0340861 | electromechanical dissociation C0340486 | induced ventricular tachycardia C0340375 | subaortic stenosis C0302148 | thrombus C0264766 | rheumatic mitral stenosis C0264733 | ventricular dilatation C0264716 | chronic heart failure C0264695 | subendocardial ischemia C0264686 | coronary embolism C0264684 | coronary arteritis C0264201 | segmental dysfunction C0262405 | cerebral dysfunction C0241885 | exercise intolerance C0240035 | interstitial fibrosis C0235574 | intravascular haemolysis C0235480 | paroxysmal atrial fibrillation C0232306 | left ventricular hypertrophy C0232305 | right ventricular hypertrophy C0232288 | exertional chest pain C0232276 | diastolic rumble C0232197 | fibrillation C0206157 | nemaline myopathy C0206146 | myocardial stunning C0206145 | stunned myocardium C0205700 | asymmetric septal hypertrophy C0155686 | acute myocarditis C0151744 | myocardial ischemia C0151744 | cardiac ischemia C0151517 | complete atrioventricular block C0149721 | lv hypertrophy C0149721 | left ventricular enlargement C0086439 | hypokinesis C0043202 | wolff-parkinson-white (wpw) syndrome C0042420 | vasovagal syncope C0040128 | thyroid diseases C0040038 | thromboembolism C0039240 | supraventricular tachycardias C0039070 | syncope C0038454 | strokes C0038454 | stroke C0035619 | right ventricular outflow obstruction C0034091 | pulmonary veno-occlusive disease C0034089 | pulmonary valve stenosis C0034063 | pulmonary oedema C0031880 | pickwickian syndrome C0027122 | muscle calcification C0027051 | myocardial infarction C0026850 | muscular dystrophy C0026267 | mitral valve prolapse C0026266 | mitral regurgitation C0026266 | mitral insufficiency C0026266 | mitral incompetence C0024141 | systemic lupus erythematosus C0023213 | left ventricular outflow obstruction C0022116 | ischemia C0022116 | ischaemia C0020649 | hypotension C0018802 | congestive heart failure C0018801 | heart failure C0018801 | cardiac failure C0016719 | friedreich's ataxia C0016522 | patent foramen ovale C0014122 | infectious endocarditis C0014118 | endocarditis C0013384 | dyskinesis C0010073 | coronary vasospasm C0010051 | coronary artery aneurysm C0008031 | chest pain C0003504 | aortic regurgitation C0002962 | stenocardia C0002962 | angina pectoris C0002940 | aneurysms C0002940 | aneurysm C0002878 | hemolytic anemia C0002878 | haemolytic anaemia |
Text Mined Symptom | UMLS | Name | Sentences' Count(Total Symptoms:51) C0232197 | fibrillation | 23 C0018801 | heart failure | 21 C0149721 | left ventricular hypertrophy | 12 C0039231 | tachycardia | 12 C0002940 | aneurysm | 8 C0022116 | ischemia | 7 C0014118 | endocarditis | 6 C0427008 | stiffness | 4 C1273070 | left ventricular diastolic dysfunction | 4 C0018802 | congestive heart failure | 4 C0018801 | cardiac failure | 4 C0235480 | paroxysmal atrial fibrillation | 3 C0023213 | left ventricular outflow obstruction | 3 C0232605 | regurgitation | 3 C0026266 | mitral regurgitation | 3 C0002986 | fabry disease | 3 C0020542 | pulmonary hypertension | 3 C0040038 | thromboembolism | 2 C0796095 | c syndrome | 2 C0014121 | infective endocarditis | 2 C0264695 | subendocardial ischemia | 2 C0344431 | monomorphic ventricular tachycardia | 2 C0519097 | left ventricular aneurysm | 2 C0039070 | syncope | 2 C0392464 | ventricular aneurysm | 1 C0008031 | chest pain | 1 C0026266 | mitral valve regurgitation | 1 C0016719 | friedreich's ataxia | 1 C0241885 | exercise intolerance | 1 C0003507 | aortic stenosis | 1 C0028326 | noonan syndrome | 1 C0746604 | mitral valve endocarditis | 1 C0002940 | aneurysms | 1 C0013922 | embolism | 1 C0149721 | lv hypertrophy | 1 C0948355 | myocardial bridging | 1 C0027051 | myocardial infarction | 1 C0155626 | acute myocardial infarction | 1 C0027051 | myocardial infarct | 1 C0042510 | ventricular fibrillation | 1 C0151517 | complete heart block | 1 C0034063 | pulmonary oedema | 1 C0151517 | complete atrioventricular block | 1 C0750197 | sustained ventricular tachycardia | 1 C0205700 | asymmetric septal hypertrophy | 1 C0013404 | dyspnea | 1 C0016169 | fistula | 1 C0020649 | hypotension | 1 C0002878 | hemolytic anemia | 1 C0022116 | ischaemia | 1 C1388902 | asynergy | 1 |
Manually Genotype(Total Text Mining Genotypes:0) |
---|
(Waiting for update.) |
Text Mining Genotype(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
All Snps(Total Genotypes:62) | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
snpId | pubmedId | geneId | geneSymbol | diseaseId | sourceId | sentence | score | Year | geneSymbol_dbSNP | CHROMOSOME | POS | REF | ALT |
rs104893823 | 18820258 | 7134 | TNNC1 | umls:C0007194 | BeFree | Two novel mutations (G159D and L29Q) in cardiac troponin C (CTnC) associate their phenotypic outcomes with dilated (DCM) and hypertrophic cardiomyopathy (HCM), respectively. | 0.009901391 | 2008 | TNNC1 | 3 | 52451285 | C | T |
rs104894201 | 24180415 | 8548 | BLZF1 | umls:C0007194 | BeFree | The human mutation R120G in the αB-crystallin (CRYAB) causes a multisystemic disease that is characterized by hypertrophic cardiomyopathy and cytoplasmic protein aggregates. | 0.000271442 | 2015 | CRYAB | 11 | 111908934 | T | C |
rs104894201 | 24180415 | 1410 | CRYAB | umls:C0007194 | BeFree | The human mutation R120G in the αB-crystallin (CRYAB) causes a multisystemic disease that is characterized by hypertrophic cardiomyopathy and cytoplasmic protein aggregates. | 0.000271442 | 2015 | CRYAB | 11 | 111908934 | T | C |
rs104894501 | 16043485 | 7168 | TPM1 | umls:C0007194 | BeFree | Five Tm mutations were chosen for this study: the hypertrophic cardiomyopathy (HCM) mutations E62Q, E180G, and L185R and the dilated cardiomyopathy (DCM) mutations E40K and E54K. | 0.033971298 | 2005 | TPM1 | 15 | 63044030 | G | A,T |
rs104894502 | 10900175 | 7168 | TPM1 | umls:C0007194 | BeFree | Effect of hypertrophic cardiomyopathy mutations in human cardiac muscle alpha -tropomyosin (Asp175Asn and Glu180Gly) on the regulatory properties of human cardiac troponin determined by in vitro motility assay. | 0.033971298 | 2000 | TPM1 | 15 | 63060915 | A | G,T |
rs104894502 | 24585742 | 7168 | TPM1 | umls:C0007194 | BeFree | We used an HCM mouse model with an E180G mutation in α-tropomyosin (Tm180) that demonstrates increased myofilament Ca(2+) sensitivity, severe hypertrophy, and diastolic dysfunction. | 0.033971298 | 2015 | TPM1 | 15 | 63060915 | A | G,T |
rs104894502 | 16043485 | 7168 | TPM1 | umls:C0007194 | BeFree | Five Tm mutations were chosen for this study: the hypertrophic cardiomyopathy (HCM) mutations E62Q, E180G, and L185R and the dilated cardiomyopathy (DCM) mutations E40K and E54K. | 0.033971298 | 2005 | TPM1 | 15 | 63060915 | A | G,T |
rs104894502 | 21376702 | 7168 | TPM1 | umls:C0007194 | BeFree | Hypertrophic cardiomyopathy-causing Asp175asn and Glu180gly Tpm1 mutations shift tropomyosin strands further towards the open position during the ATPase cycle. | 0.033971298 | 2011 | TPM1 | 15 | 63060915 | A | G,T |
rs104894503 | 18394456 | 4879 | NPPB | umls:C0007194 | BeFree | In conclusion, in patients with nonobstructive HC attributable to an Asp175Asn mutation in the alpha-tropomyosin gene, elevated NT-pro-BNP levels are associated with incipient LV remodeling, suggesting that NT-pro-BNP could be used to diagnose insidious unfavorable LV remodeling in HC. | 0.005991584 | 2008 | TPM1 | 15 | 63060899 | G | A |
rs104894503 | 12473556 | 4625 | MYH7 | umls:C0007194 | BeFree | Genotype-phenotype correlative studies have implicated 8 particular mutations that cause hypertrophic cardiomyopathy (HCM) as benign defects, associated with near-normal survival: N232S, G256E, F513C, V606M, R719Q, and L908V of beta-myosin heavy chain (MYH7); S179F of troponin T (TNNT2); and D175N of alpha-tropomyosin (TPM1). | 0.05446026 | 2002 | TPM1 | 15 | 63060899 | G | A |
rs104894503 | 24888384 | 5554 | PRH1 | umls:C0007194 | BeFree | In the nationwide FinHCM Study including 306 Finnish patients with hypertrophic cardiomyopathy (HCM), we have previously identified two founder mutations in the alpha-tropomyosin (TPM1-D175N) and myosin-binding protein C (MYBPC3-Q1061X) genes, accounting for 18% of all cases.Objective. | 0.010586233 | 2015 | TPM1 | 15 | 63060899 | G | A |
rs104894503 | 9060904 | 7168 | TPM1 | umls:C0007194 | BeFree | In contrast, prognosis reflected genotype; near normal life expectancy is found in hypertrophic cardiomyopathy caused by the alpha-tropomyosin mutation Asp175Asn. | 0.033971298 | 1997 | TPM1 | 15 | 63060899 | G | A |
rs104894503 | 18394456 | 7168 | TPM1 | umls:C0007194 | BeFree | Significance of plasma levels of N-terminal Pro-B-type natriuretic peptide on left ventricular remodeling in non-obstructive hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the alpha-tropomyosin gene. | 0.033971298 | 2008 | TPM1 | 15 | 63060899 | G | A |
rs104894503 | 12473556 | 7139 | TNNT2 | umls:C0007194 | BeFree | Genotype-phenotype correlative studies have implicated 8 particular mutations that cause hypertrophic cardiomyopathy (HCM) as benign defects, associated with near-normal survival: N232S, G256E, F513C, V606M, R719Q, and L908V of beta-myosin heavy chain (MYH7); S179F of troponin T (TNNT2); and D175N of alpha-tropomyosin (TPM1). | 0.155829122 | 2002 | TPM1 | 15 | 63060899 | G | A |
rs104894503 | 16014439 | 7168 | TPM1 | umls:C0007194 | BeFree | Cine MR imaging of myocardial contractile impairment in patients with hypertrophic cardiomyopathy attributable to Asp175Asn mutation in the alpha-tropomyosin gene. | 0.033971298 | 2005 | TPM1 | 15 | 63060899 | G | A |
rs104894503 | 17556170 | 7168 | TPM1 | umls:C0007194 | BeFree | Myocardial perfusion, oxidative metabolism, and free fatty acid uptake in patients with hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the alpha-tropomyosin gene: a positron emission tomography study. | 0.033971298 | 2007 | TPM1 | 15 | 63060899 | G | A |
rs104894503 | 12511681 | 7168 | TPM1 | umls:C0007194 | BeFree | To assess first-pass magnetic resonance (MR) imaging in the evaluation of perfusion impairment in a genetically homogeneous population of patients with hypertrophic cardiomyopathy (HCM) and the Asp175Asn mutation of the alpha-tropomyosin gene and to evaluate the association between hypertrophy and perfusion. | 0.033971298 | 2003 | TPM1 | 15 | 63060899 | G | A |
rs104894503 | 24888384 | 7168 | TPM1 | umls:C0007194 | BeFree | In the nationwide FinHCM Study including 306 Finnish patients with hypertrophic cardiomyopathy (HCM), we have previously identified two founder mutations in the alpha-tropomyosin (TPM1-D175N) and myosin-binding protein C (MYBPC3-Q1061X) genes, accounting for 18% of all cases.Objective. | 0.033971298 | 2015 | TPM1 | 15 | 63060899 | G | A |
rs104894503 | 10900175 | 7168 | TPM1 | umls:C0007194 | BeFree | Effect of hypertrophic cardiomyopathy mutations in human cardiac muscle alpha -tropomyosin (Asp175Asn and Glu180Gly) on the regulatory properties of human cardiac troponin determined by in vitro motility assay. | 0.033971298 | 2000 | TPM1 | 15 | 63060899 | G | A |
rs104894503 | 14734051 | 7168 | TPM1 | umls:C0007194 | BeFree | Inducibility of life-threatening ventricular arrhythmias is related to maximum left ventricular thickness and clinical markers of sudden cardiac death in patients with hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the alpha-tropomyosin gene. | 0.033971298 | 2004 | TPM1 | 15 | 63060899 | G | A |
rs104894503 | 21376702 | 7168 | TPM1 | umls:C0007194 | BeFree | Hypertrophic cardiomyopathy-causing Asp175asn and Glu180gly Tpm1 mutations shift tropomyosin strands further towards the open position during the ATPase cycle. | 0.033971298 | 2011 | TPM1 | 15 | 63060899 | G | A |
rs104894505 | 16043485 | 7168 | TPM1 | umls:C0007194 | BeFree | Five Tm mutations were chosen for this study: the hypertrophic cardiomyopathy (HCM) mutations E62Q, E180G, and L185R and the dilated cardiomyopathy (DCM) mutations E40K and E54K. | 0.033971298 | 2005 | TPM1 | 15 | 63044072 | G | A |
rs104894724 | 12242271 | 7137 | TNNI3 | umls:C0007194 | BeFree | The heightened Ca2+ sensitivity of force found with hypertrophic cardiomyopathy (HCM)-associated mutant cardiac troponin I (cTnIR145G; R146G in rodents) has been postulated to be an underlying cause of hypertrophic growth and premature sudden death in humans and in animal models of the disease. | 0.040810884 | 2002 | TNNI3 | 19 | 55154146 | G | C,A |
rs104894724 | 18430738 | 7137 | TNNI3 | umls:C0007194 | BeFree | Functional consequences of the human cardiac troponin I hypertrophic cardiomyopathy mutation R145G in transgenic mice. | 0.040810884 | 2008 | TNNI3 | 19 | 55154146 | G | C,A |
rs116840805 | 14645200 | 859 | CAV3 | umls:C0007194 | BeFree | Overexpression of P104L mutant caveolin-3 in mice develops hypertrophic cardiomyopathy with enhanced contractility in association with increased endothelial nitric oxide synthase activity. | 0.000814326 | 2004 | CAV3;SSUH2 | 3 | 8745725 | C | T |
rs116840805 | 14645200 | 4846 | NOS3 | umls:C0007194 | BeFree | Overexpression of P104L mutant caveolin-3 in mice develops hypertrophic cardiomyopathy with enhanced contractility in association with increased endothelial nitric oxide synthase activity. | 0.005991584 | 2004 | CAV3;SSUH2 | 3 | 8745725 | C | T |
rs121908991 | 17667862 | 353 | APRT | umls:C0007194 | BeFree | The report of a pathogenic mutation (R531Q) in the gene (PRKAG2) encoding the gamma2 subunit of AMP-activated protein kinase (AMPK) in three infants with congenital hypertrophic cardiomyopathy, glycogen storage, and pseudo PHK deficiency prompted us to screen this gene in our patient. | 0.001357209 | 2007 | PRKAG2 | 7 | 151560610 | C | T,A |
rs121908991 | 15877279 | 51422 | PRKAG2 | umls:C0007194 | BeFree | Thus, recurrent heterozygous R531Q missense mutations in PRKAG2 give rise to a massive nonlysosomal cardiac glycogenosis of fetal symptomatic onset and rapidly fatal course, constituting a genotypically and clinically distinct variant of hypertrophic cardiomyopathy with Wolff-Parkinson-White syndrome. | 0.011615919 | 2005 | PRKAG2 | 7 | 151560610 | C | T,A |
rs121908991 | 17667862 | 51422 | PRKAG2 | umls:C0007194 | BeFree | The report of a pathogenic mutation (R531Q) in the gene (PRKAG2) encoding the gamma2 subunit of AMP-activated protein kinase (AMPK) in three infants with congenital hypertrophic cardiomyopathy, glycogen storage, and pseudo PHK deficiency prompted us to screen this gene in our patient. | 0.011615919 | 2007 | PRKAG2 | 7 | 151560610 | C | T,A |
rs121913624 | 24928957 | 4625 | MYH7 | umls:C0007194 | BeFree | Faster cross-bridge detachment and increased tension cost in human hypertrophic cardiomyopathy with the R403Q MYH7 mutation. | 0.05446026 | 2015 | MYH7 | 14 | 23429278 | C | T,A |
rs121913627 | 24566549 | 6520 | SLC3A2 | umls:C0007194 | BeFree | In this study we aimed to detect the presence of R403QLW, V606M, K615N, and R663H mutations in beta-myosin heavy-chain gene (MYH7) and figure out the genotype-phenotype correlations in Turkish patients with HCM. | 0.022258234 | 2015 | MYH7 | 14 | 23427657 | C | T |
rs121913627 | 24566549 | 4625 | MYH7 | umls:C0007194 | BeFree | In this study we aimed to detect the presence of R403QLW, V606M, K615N, and R663H mutations in beta-myosin heavy-chain gene (MYH7) and figure out the genotype-phenotype correlations in Turkish patients with HCM. | 0.05446026 | 2015 | MYH7 | 14 | 23427657 | C | T |
rs121913627 | 12473556 | 7139 | TNNT2 | umls:C0007194 | BeFree | Genotype-phenotype correlative studies have implicated 8 particular mutations that cause hypertrophic cardiomyopathy (HCM) as benign defects, associated with near-normal survival: N232S, G256E, F513C, V606M, R719Q, and L908V of beta-myosin heavy chain (MYH7); S179F of troponin T (TNNT2); and D175N of alpha-tropomyosin (TPM1). | 0.155829122 | 2002 | MYH7 | 14 | 23427657 | C | T |
rs121913627 | 12473556 | 4625 | MYH7 | umls:C0007194 | BeFree | Genotype-phenotype correlative studies have implicated 8 particular mutations that cause hypertrophic cardiomyopathy (HCM) as benign defects, associated with near-normal survival: N232S, G256E, F513C, V606M, R719Q, and L908V of beta-myosin heavy chain (MYH7); S179F of troponin T (TNNT2); and D175N of alpha-tropomyosin (TPM1). | 0.05446026 | 2002 | MYH7 | 14 | 23427657 | C | T |
rs121913627 | 17383184 | 4625 | MYH7 | umls:C0007194 | BeFree | Here, we describe a unique combination of hypertrophic cardiomyopathy and hypertrophic distal myopathy in a family with a MYH7 Val606Met mutation (exon 16). | 0.05446026 | 2007 | MYH7 | 14 | 23427657 | C | T |
rs121913631 | 12473556 | 7139 | TNNT2 | umls:C0007194 | BeFree | Genotype-phenotype correlative studies have implicated 8 particular mutations that cause hypertrophic cardiomyopathy (HCM) as benign defects, associated with near-normal survival: N232S, G256E, F513C, V606M, R719Q, and L908V of beta-myosin heavy chain (MYH7); S179F of troponin T (TNNT2); and D175N of alpha-tropomyosin (TPM1). | 0.155829122 | 2002 | MYH7 | 14 | 23424107 | G | C |
rs121913631 | 12473556 | 4625 | MYH7 | umls:C0007194 | BeFree | Genotype-phenotype correlative studies have implicated 8 particular mutations that cause hypertrophic cardiomyopathy (HCM) as benign defects, associated with near-normal survival: N232S, G256E, F513C, V606M, R719Q, and L908V of beta-myosin heavy chain (MYH7); S179F of troponin T (TNNT2); and D175N of alpha-tropomyosin (TPM1). | 0.05446026 | 2002 | MYH7 | 14 | 23424107 | G | C |
rs121913633 | 12473556 | 7139 | TNNT2 | umls:C0007194 | BeFree | Genotype-phenotype correlative studies have implicated 8 particular mutations that cause hypertrophic cardiomyopathy (HCM) as benign defects, associated with near-normal survival: N232S, G256E, F513C, V606M, R719Q, and L908V of beta-myosin heavy chain (MYH7); S179F of troponin T (TNNT2); and D175N of alpha-tropomyosin (TPM1). | 0.155829122 | 2002 | MYH7 | 14 | 23431447 | C | T |
rs121913633 | 12473556 | 4625 | MYH7 | umls:C0007194 | BeFree | Genotype-phenotype correlative studies have implicated 8 particular mutations that cause hypertrophic cardiomyopathy (HCM) as benign defects, associated with near-normal survival: N232S, G256E, F513C, V606M, R719Q, and L908V of beta-myosin heavy chain (MYH7); S179F of troponin T (TNNT2); and D175N of alpha-tropomyosin (TPM1). | 0.05446026 | 2002 | MYH7 | 14 | 23431447 | C | T |
rs121913636 | 12473556 | 4625 | MYH7 | umls:C0007194 | BeFree | Genotype-phenotype correlative studies have implicated 8 particular mutations that cause hypertrophic cardiomyopathy (HCM) as benign defects, associated with near-normal survival: N232S, G256E, F513C, V606M, R719Q, and L908V of beta-myosin heavy chain (MYH7); S179F of troponin T (TNNT2); and D175N of alpha-tropomyosin (TPM1). | 0.05446026 | 2002 | MYH7 | 14 | 23428540 | A | C |
rs121913636 | 12473556 | 7139 | TNNT2 | umls:C0007194 | BeFree | Genotype-phenotype correlative studies have implicated 8 particular mutations that cause hypertrophic cardiomyopathy (HCM) as benign defects, associated with near-normal survival: N232S, G256E, F513C, V606M, R719Q, and L908V of beta-myosin heavy chain (MYH7); S179F of troponin T (TNNT2); and D175N of alpha-tropomyosin (TPM1). | 0.155829122 | 2002 | MYH7 | 14 | 23428540 | A | C |
rs121913641 | 12473556 | 7139 | TNNT2 | umls:C0007194 | BeFree | Genotype-phenotype correlative studies have implicated 8 particular mutations that cause hypertrophic cardiomyopathy (HCM) as benign defects, associated with near-normal survival: N232S, G256E, F513C, V606M, R719Q, and L908V of beta-myosin heavy chain (MYH7); S179F of troponin T (TNNT2); and D175N of alpha-tropomyosin (TPM1). | 0.155829122 | 2002 | MYH7 | 14 | 23425970 | C | T |
rs121913641 | 12473556 | 4625 | MYH7 | umls:C0007194 | BeFree | Genotype-phenotype correlative studies have implicated 8 particular mutations that cause hypertrophic cardiomyopathy (HCM) as benign defects, associated with near-normal survival: N232S, G256E, F513C, V606M, R719Q, and L908V of beta-myosin heavy chain (MYH7); S179F of troponin T (TNNT2); and D175N of alpha-tropomyosin (TPM1). | 0.05446026 | 2002 | MYH7 | 14 | 23425970 | C | T |
rs121964857 | 20038417 | 7139 | TNNT2 | umls:C0007194 | BeFree | We studied the TNNT2 gene in 127 patients with hypertrophic cardiomyopathy and identified three mutations in patients from four families (3.1%): the Phe87Leu mutation, which has not been previously reported, the Arg278Cys mutation (two families) and the Asp271Ile mutation. | 0.155829122 | 2009 | TNNT2 | 1 | 201359245 | G | A |
rs148395034 | 24436435 | 84676 | TRIM63 | umls:C0007194 | BeFree | Does p.Q247X in TRIM63 cause human hypertrophic cardiomyopathy? | 0.000814326 | 2014 | TRIM63 | 1 | 26058482 | G | A |
rs1799983 | 15778808 | 4846 | NOS3 | umls:C0007194 | BeFree | Endothelial nitric oxide synthase gene polymorphism (Glu298Asp) in patients with coexistent hypertrophic cardiomyopathy and coronary spastic angina. | 0.005991584 | 2005 | NOS3 | 7 | 150999023 | T | G |
rs199476305 | 16043485 | 7168 | TPM1 | umls:C0007194 | BeFree | Five Tm mutations were chosen for this study: the hypertrophic cardiomyopathy (HCM) mutations E62Q, E180G, and L185R and the dilated cardiomyopathy (DCM) mutations E40K and E54K. | 0.033971298 | 2005 | TPM1 | 15 | 63044096 | G | C |
rs199476314 | 16043485 | 7168 | TPM1 | umls:C0007194 | BeFree | Five Tm mutations were chosen for this study: the hypertrophic cardiomyopathy (HCM) mutations E62Q, E180G, and L185R and the dilated cardiomyopathy (DCM) mutations E40K and E54K. | 0.033971298 | 2005 | TPM1 | 15 | 63060930 | T | G |
rs200422162 | 24888384 | 5554 | PRH1 | umls:C0007194 | BeFree | In the nationwide FinHCM Study including 306 Finnish patients with hypertrophic cardiomyopathy (HCM), we have previously identified two founder mutations in the alpha-tropomyosin (TPM1-D175N) and myosin-binding protein C (MYBPC3-Q1061X) genes, accounting for 18% of all cases.Objective. | 0.010586233 | 2015 | PRH1;TAS2R43;PRH1-PRR4;PRH1-TAS2R14 | 12 | 11091704 | T | C |
rs200422162 | 24888384 | 7168 | TPM1 | umls:C0007194 | BeFree | In the nationwide FinHCM Study including 306 Finnish patients with hypertrophic cardiomyopathy (HCM), we have previously identified two founder mutations in the alpha-tropomyosin (TPM1-D175N) and myosin-binding protein C (MYBPC3-Q1061X) genes, accounting for 18% of all cases.Objective. | 0.033971298 | 2015 | PRH1;TAS2R43;PRH1-PRR4;PRH1-TAS2R14 | 12 | 11091704 | T | C |
rs201786090 | 24730657 | 11155 | LDB3 | umls:C0007194 | BeFree | Here we report the identification of a highly conserved ZASP G54S mutation classified as a variant of unknown significance in a sample of an adult with hypertrophic cardiomyopathy (HCM). | 0.002638474 | 2015 | LDB3 | 10 | 86679433 | G | A |
rs267607123 | 19506933 | 7134 | TNNC1 | umls:C0007194 | BeFree | The cardiac troponin C mutation Leu29Gln found in a patient with hypertrophic cardiomyopathy does not alter contractile parameters in skinned murine myocardium. | 0.009901391 | 2009 | TNNC1 | 3 | 52452222 | A | T |
rs267607123 | 18820258 | 7134 | TNNC1 | umls:C0007194 | BeFree | Two novel mutations (G159D and L29Q) in cardiac troponin C (CTnC) associate their phenotypic outcomes with dilated (DCM) and hypertrophic cardiomyopathy (HCM), respectively. | 0.009901391 | 2008 | TNNC1 | 3 | 52452222 | A | T |
rs267607128 | 22086914 | 7137 | TNNI3 | umls:C0007194 | BeFree | Generation and functional characterization of knock-in mice harboring the cardiac troponin I-R21C mutation associated with hypertrophic cardiomyopathy. | 0.040810884 | 2012 | TNNI3 | 19 | 55157097 | G | A |
rs267607128 | 25961037 | 7137 | TNNI3 | umls:C0007194 | BeFree | We investigated the effect of the hypertrophic cardiomyopathy-linked R21C (arginine to cysteine) mutation in human cardiac troponin I (cTnI) on the contractile properties and myofilament protein phosphorylation in papillary muscle preparations from left (LV) and right (RV) ventricles of homozygous R21C(+/+) knock-in mice. | 0.040810884 | 2014 | TNNI3 | 19 | 55157097 | G | A |
rs397507550 | 21910226 | 5781 | PTPN11 | umls:C0007194 | BeFree | Implantable cardioverter defibrillator for progressive hypertrophic cardiomyopathy in a patient with LEOPARD syndrome and a novel PTPN11 mutation Gln510His. | 0.004071628 | 2011 | PTPN11 | 12 | 112489106 | G | C |
rs397515985 | 21832052 | 4607 | MYBPC3 | umls:C0007194 | BeFree | One variant (D145E) that was previously reported in association with hypertrophic cardiomyopathy and that produced results in vivo in this study consistent with prior hypertrophic cardiomyopathy functional studies was found associated with the MYBPC3 P910T rare variant, likely contributing to the observed DCM phenotype. | 0.206789095 | 2011 | MYBPC3 | 11 | 47335886 | G | T |
rs397516847 | 22489623 | 7134 | TNNC1 | umls:C0007194 | BeFree | The objective of this work was to investigate the effect of hypertrophic cardiomyopathy-linked A8V and E134D mutations in cardiac troponin C (cTnC) on the response of reconstituted thin filaments to calcium upon phosphorylation of cardiac troponin I (cTnI) by protein kinase A. | 0.009901391 | 2012 | TNNC1 | 3 | 52451443 | C | A |
rs397516847 | 22489623 | 7137 | TNNI3 | umls:C0007194 | BeFree | The objective of this work was to investigate the effect of hypertrophic cardiomyopathy-linked A8V and E134D mutations in cardiac troponin C (cTnC) on the response of reconstituted thin filaments to calcium upon phosphorylation of cardiac troponin I (cTnI) by protein kinase A. | 0.040810884 | 2012 | TNNC1 | 3 | 52451443 | C | A |
rs77615401 | 18175163 | 7137 | TNNI3 | umls:C0007194 | BeFree | The TNNI3 alteration, replacing proline with serine (Pro82Ser), has been previously implicated in elderly-onset hypertrophic cardiomyopathy, although its pathogenicity is not clear. | 0.040810884 | 2008 | TNNI3 | 19 | 55156239 | G | A |
rs80190679 | 12473556 | 7139 | TNNT2 | umls:C0007194 | BeFree | Genotype-phenotype correlative studies have implicated 8 particular mutations that cause hypertrophic cardiomyopathy (HCM) as benign defects, associated with near-normal survival: N232S, G256E, F513C, V606M, R719Q, and L908V of beta-myosin heavy chain (MYH7); S179F of troponin T (TNNT2); and D175N of alpha-tropomyosin (TPM1). | 0.155829122 | 2002 | SLC3A2 | 11 | 62881991 | G | A |
rs80190679 | 12473556 | 4625 | MYH7 | umls:C0007194 | BeFree | Genotype-phenotype correlative studies have implicated 8 particular mutations that cause hypertrophic cardiomyopathy (HCM) as benign defects, associated with near-normal survival: N232S, G256E, F513C, V606M, R719Q, and L908V of beta-myosin heavy chain (MYH7); S179F of troponin T (TNNT2); and D175N of alpha-tropomyosin (TPM1). | 0.05446026 | 2002 | SLC3A2 | 11 | 62881991 | G | A |
GWASdb Annotation(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
GWASdb Snp Trait(Total Genotypes:187) | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHR | POS | SNPID | REF | ALT | ORI_SNPID | PMID | P_VALUE | P_VALUE_TEXT | OR/BETA | CI95_TEXT | GWAS_INITIAL_SAMPLE_SIZE | SUB_POPULATION | SUPER_POPULATION | GWAS_TRAIT | HPO_ID | HPO_TERM | DO_ID | DO_TERM | MESH_ID | MESH_TERM | EFO_ID | EFO_TERM | DOLITE_TERM | RISK_ALLELE | PUBLICATION_TYPE | AA | GENE_SYMBOL | TYPE | REFGENE |
1 | 43596384 | rs16830359 | G | A | rs16830359 | 21348951 | 1.00E-07 | additive, recessive | NA | NA | 851 Old Order Amish individuals | Amish(851) | ALL(851) | EUR(851) | ALL(851) | Cardiac hypertrophy | HPOID:0001639 | Hypertrophic cardiomyopathy | DOID:11984 | hypertrophic cardiomyopathy | D006332 | Cardiomegaly | EFOID:0002503 | cardiac hypertrophy | Heart disease | NA | Research Support, N.I.H., Extramural | G | NA |
1 | 97898232 | rs7517433 | T | C | rs7517433 | pha003052 | 3.50E-05 | phs000221 | phs000501 | 0.26 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs7517433-T | NA | T | DPYD | intron |
1 | 97908878 | rs1415681 | T | G | rs1415681 | pha003052 | 4.08E-05 | phs000221 | phs000501 | 0.26 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs1415681-T | NA | T | DPYD | intron |
1 | 158074220 | rs17421546 | G | A | rs17421546 | pha003052 | 6.95E-05 | phs000221 | phs000501 | 0.39 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs17421546-A | NA | G | NA | NA |
1 | 167739821 | rs4472738 | C | A | rs4472738 | pha003052 | 6.87E-05 | phs000221 | phs000501 | 0.2 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs4472738-A | NA | A | MPZL1 | intron |
1 | 196024294 | rs1451916 | A | C | rs1451916 | pha003052 | 7.38E-05 | phs000221 | phs000501 | 0.23 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs1451916-C | NA | T | NA | NA |
1 | 196024294 | rs375562694 | A | AT | rs1451916 | pha003052 | 7.38E-05 | phs000221 | phs000501 | 0.23 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs1451916-C | NA | T | NA | NA |
1 | 196024294 | rs549773131 | A | AT | rs1451916 | pha003052 | 7.38E-05 | phs000221 | phs000501 | 0.23 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs1451916-C | NA | T | NA | NA |
1 | 200471464 | rs6680807 | C | A | rs6680807 | pha003052 | 9.97E-05 | phs000221 | phs000501 | 0.26 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs6680807-C | NA | A | NA | NA |
1 | 208757586 | rs17259784 | G | C | rs17259784 | 21348951 | 6.00E-06 | recessive | NA | NA | 851 Old Order Amish individuals | Amish(851) | ALL(851) | EUR(851) | ALL(851) | Cardiac hypertrophy | HPOID:0001639 | Hypertrophic cardiomyopathy | DOID:11984 | hypertrophic cardiomyopathy | D006332 | Cardiomegaly | EFOID:0002503 | cardiac hypertrophy | Heart disease | NA | Research Support, N.I.H., Extramural | G | NA |
1 | 216716537 | rs12757165 | A | G | rs12757165 | 21348951 | 1.00E-07 | additive | NA | NA | 851 Old Order Amish individuals | Amish(851) | ALL(851) | EUR(851) | ALL(851) | Cardiac hypertrophy | HPOID:0001639 | Hypertrophic cardiomyopathy | DOID:11984 | hypertrophic cardiomyopathy | D006332 | Cardiomegaly | EFOID:0002503 | cardiac hypertrophy | Heart disease | NA | Research Support, N.I.H., Extramural | A | ESRRG |
1 | 218036817 | rs11117953 | G | A | rs11117953 | pha003052 | 7.11E-05 | phs000221 | phs000501 | 0.41 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs11117953-A | NA | G | SPATA17 | intron |
1 | 234382599 | rs12119646 | T | C | rs12119646 | pha003052 | 4.25E-05 | phs000221 | phs000501 | 0.33 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs12119646-C | NA | T | SLC35F3 | intron |
1 | 234384658 | rs12024374 | G | A | rs12024374 | pha003052 | 4.80E-05 | phs000221 | phs000501 | 0.33 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs12024374-A | NA | G | SLC35F3 | intron |
2 | 15229630 | rs13391879 | T | C | rs13391879 | pha003052 | 9.73E-05 | phs000221 | phs000501 | 0.3 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs13391879-C | NA | C | NA | NA |
2 | 31570689 | rs4952085 | G | A | rs4952085 | pha003052 | 5.18E-05 | phs000221 | phs000501 | 0.22 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs4952085-G | NA | A | XDH | intron |
2 | 31571786 | rs1884725 | A | G | rs1884725 | pha003052 | 6.81E-05 | phs000221 | phs000501 | 0.22 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs1884725-A | NA | G | XDH | cds-synon |
2 | 71403616 | rs413693 | T | G | rs413693 | pha003052 | 1.48E-06 | phs000221 | phs000501 | 0.28 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs413693-G | NA | T | NA | NA |
2 | 71436269 | rs2418896 | G | A | rs2418896 | pha003052 | 2.76E-06 | phs000221 | phs000501 | 0.28 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs2418896-G | NA | A | PAIP2B | intron |
2 | 71703364 | rs12477276 | A | G | rs12477276 | pha003052 | 4.20E-06 | phs000221 | phs000501 | 0.21 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs12477276-G | NA | G | DYSF | intron |
2 | 102690727 | rs12624116 | C | T | rs12624116 | pha003052 | 7.37E-05 | phs000221 | phs000501 | 0.24 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs12624116-T | NA | C | NA | NA |
2 | 102691310 | rs1558644 | A | G | rs1558644 | pha003052 | 5.20E-05 | phs000221 | phs000501 | 0.24 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs1558644-G | NA | T | NA | NA |
2 | 137407012 | rs6711718 | T | C | rs6711718 | pha003052 | 5.14E-05 | phs000221 | phs000501 | 0.19 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs6711718-T | NA | T | NA | NA |
2 | 137493912 | rs12476818 | T | C | rs12476818 | pha003052 | 9.60E-05 | phs000221 | phs000501 | 0.28 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs12476818-C | NA | T | NA | NA |
2 | 137495815 | rs12479021 | T | G | rs12479021 | pha003052 | 7.44E-05 | phs000221 | phs000501 | 0.28 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs12479021-G | NA | T | NA | NA |
2 | 213165193 | rs17346933 | A | G | rs17346933 | pha003052 | 5.77E-05 | phs000221 | phs000501 | 0.23 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs17346933-G | NA | A | ERBB4 | intron |
3 | 12626516 | rs3729931 | G | A | rs3729931 | 21348951 | 7.00E-07 | dominant | NA | NA | 851 Old Order Amish individuals | Amish(851) | ALL(851) | EUR(851) | ALL(851) | Cardiac hypertrophy | HPOID:0001639 | Hypertrophic cardiomyopathy | DOID:11984 | hypertrophic cardiomyopathy | D006332 | Cardiomegaly | EFOID:0002503 | cardiac hypertrophy | Heart disease | NA | Research Support, N.I.H., Extramural | T | RAF1 |
3 | 29357063 | rs6549924 | C | T | rs6549924 | pha003052 | 3.58E-06 | phs000221 | phs000501 | 0.22 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs6549924-T | NA | C | RBMS3 | intron |
3 | 29445931 | rs13079920 | G | A | rs13079920 | pha003052 | 8.58E-05 | phs000221 | phs000501 | 0.19 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs13079920-A | NA | G | RBMS3 | intron |
3 | 38940741 | rs4676588 | C | T | rs4676588 | pha003052 | 9.55E-06 | phs000221 | phs000501 | 0.22 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs4676588-C | NA | G | SCN11A | intron |
3 | 38958010 | rs11716902 | G | T | rs11716902 | pha003052 | 6.09E-06 | phs000221 | phs000501 | 0.21 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs11716902-G | NA | G | SCN11A | intron |
3 | 42433305 | rs17074351 | T | C | rs17074351 | pha003052 | 8.27E-05 | phs000221 | phs000501 | 0.2 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs17074351-C | NA | T | NA | NA |
3 | 61227198 | rs6802718 | G | A | rs6802718 | pha003052 | 9.76E-05 | phs000221 | phs000501 | 0.2 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs6802718-A | NA | A | FHIT | intron |
3 | 76954766 | rs1166994 | A | C | rs1166994 | pha003052 | 5.02E-05 | phs000221 | phs000501 | 0.2 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs1166994-A | NA | A | ROBO2 | intron |
3 | 109204413 | rs769554 | C | T | rs769554 | 21348951 | 3.00E-06 | additive | NA | NA | 851 Old Order Amish individuals | Amish(851) | ALL(851) | EUR(851) | ALL(851) | Cardiac hypertrophy | HPOID:0001639 | Hypertrophic cardiomyopathy | DOID:11984 | hypertrophic cardiomyopathy | D006332 | Cardiomegaly | EFOID:0002503 | cardiac hypertrophy | Heart disease | NA | Research Support, N.I.H., Extramural | G | FLJ25363 |
3 | 170419712 | rs531404 | A | G | rs531404 | pha003052 | 5.27E-05 | phs000221 | phs000501 | 0.4 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs531404-A | NA | C | NA | NA |
4 | 12538050 | rs12511228 | T | C | rs12511228 | pha003052 | 3.04E-06 | phs000221 | phs000501 | 0.31 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs12511228-T | NA | C | NA | NA |
4 | 21735319 | rs7697475 | A | G | rs7697475 | pha003052 | 9.71E-05 | phs000221 | phs000501 | 0.21 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs7697475-G | NA | G | KCNIP4 | intron |
4 | 21781997 | rs1868744 | A | C | rs1868744 | pha003052 | 9.89E-05 | phs000221 | phs000501 | 0.21 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs1868744-A | NA | A | KCNIP4 | intron |
4 | 84287807 | rs4320128 | A | G | rs4320128 | pha003052 | 9.78E-05 | phs000221 | phs000501 | 0.18 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs4320128-A | NA | A | NA | NA |
4 | 110017182 | rs11736110 | C | T | rs11736110 | pha003052 | 9.54E-05 | phs000221 | phs000501 | 0.38 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs11736110-T | NA | C | COL25A1 | intron |
4 | 164474770 | rs9631750 | T | C | rs9631750 | pha003052 | 7.89E-06 | phs000221 | phs000501 | 0.38 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs9631750-C | NA | T | MARCH1 | intron |
4 | 189144799 | rs3924963 | C | T | rs3924963 | pha003052 | 1.90E-05 | phs000221 | phs000501 | 0.27 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs3924963-C | NA | C | NA | NA |
5 | 2856417 | rs2934543 | C | T | rs2934543 | pha003052 | 9.23E-05 | phs000221 | phs000501 | 0.26 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs2934543-C | NA | A | NA | NA |
5 | 2861216 | rs16870583 | T | C | rs16870583 | pha003052 | 5.06E-05 | phs000221 | phs000501 | 0.27 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs16870583-C | NA | T,C | NA | NA |
5 | 19739333 | rs1158558 | G | T | rs1158558 | pha003052 | 8.06E-05 | phs000221 | phs000501 | 0.27 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs1158558-G | NA | C | CDH18 | intron |
5 | 83232813 | rs4368707 | C | A | rs4368707 | pha003052 | 4.50E-05 | phs000221 | phs000501 | 0.21 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs4368707-C | NA | C | NA | NA |
5 | 85611991 | rs16902182 | T | C | rs16902182 | pha003052 | 2.53E-05 | phs000221 | phs000501 | 0.44 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs16902182-C | NA | C | NA | NA |
5 | 85631025 | rs10514277 | C | A | rs10514277 | pha003052 | 4.25E-05 | phs000221 | phs000501 | 0.44 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs10514277-A | NA | C | NA | NA |
5 | 86905677 | rs4976236 | T | G | rs4976236 | pha003052 | 1.34E-06 | phs000221 | phs000501 | 0.44 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs4976236-G | NA | T | NA | NA |
5 | 86913066 | rs11749237 | A | G | rs11749237 | pha003052 | 9.34E-05 | phs000221 | phs000501 | 0.29 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs11749237-G | NA | C | NA | NA |
5 | 86972448 | rs840814 | G | A | rs840814 | pha003052 | 1.12E-06 | phs000221 | phs000501 | 0.45 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs840814-A | NA | G | NA | NA |
5 | 87000310 | rs866821 | C | T | rs866821 | pha003052 | 6.54E-05 | phs000221 | phs000501 | 0.3 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs866821-T | NA | T | NA | NA |
5 | 87001557 | rs840831 | G | A | rs840831 | pha003052 | 1.12E-06 | phs000221 | phs000501 | 0.45 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs840831-A | NA | A | NA | NA |
5 | 87450438 | rs4916890 | T | C | rs4916890 | pha003052 | 1.45E-05 | phs000221 | phs000501 | 0.41 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs4916890-T | NA | C | NA | NA |
5 | 111532234 | rs11739263 | A | G | rs11739263 | pha003052 | 3.59E-05 | phs000221 | phs000501 | 0.33 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs11739263-G | NA | A | EPB41L4A | intron |
5 | 142017860 | rs152528 | C | T | rs152528 | 21348951 | 8.00E-07 | recessive | NA | NA | 851 Old Order Amish individuals | Amish(851) | ALL(851) | EUR(851) | ALL(851) | Cardiac hypertrophy | HPOID:0001639 | Hypertrophic cardiomyopathy | DOID:11984 | hypertrophic cardiomyopathy | D006332 | Cardiomegaly | EFOID:0002503 | cardiac hypertrophy | Heart disease | NA | Research Support, N.I.H., Extramural | G | FGF1 |
5 | 174846655 | rs265992 | C | A | rs265992 | 21828061 | 1.20E-06 | Left ventricular hypertrophy (LVH) assessed by electrocardiogram (ECG) | NA | NA | 398 Korean cases; 8432 Korean controls | Korean(8830) | ALL(8830) | ASN(8830) | ALL(8830) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | NA | Research Support, Non-U.S. Gov't | C | NA |
5 | 178950761 | rs1344158 | G | A | rs1344158 | pha003052 | 8.27E-05 | phs000221 | phs000501 | 0.19 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs1344158-A | NA | G | NA | NA |
6 | 858970 | rs1572438 | C | T | rs1572438 | pha003052 | 4.00E-05 | phs000221 | phs000501 | 0.2 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs1572438-T | NA | G | NA | NA |
6 | 22246604 | rs4236016 | C | T | rs4236016 | 21348951 | 4.00E-06 | additive, recessive | NA | NA | 851 Old Order Amish individuals | Amish(851) | ALL(851) | EUR(851) | ALL(851) | Cardiac hypertrophy | HPOID:0001639 | Hypertrophic cardiomyopathy | DOID:11984 | hypertrophic cardiomyopathy | D006332 | Cardiomegaly | EFOID:0002503 | cardiac hypertrophy | Heart disease | NA | Research Support, N.I.H., Extramural | T | NA |
6 | 24333744 | rs4504468 | T | G | rs4504468 | pha003052 | 9.38E-05 | phs000221 | phs000501 | 0.19 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs4504468-T | NA | T | DCDC2 | intron |
6 | 24654266 | rs9295629 | G | A | rs9295629 | 21828061 | 9.00E-06 | Left ventricular hypertrophy (LVH) assessed by electrocardiogram (ECG) | NA | NA | 398 Korean cases; 8432 Korean controls | Korean(8830) | ALL(8830) | ASN(8830) | ALL(8830) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | NA | Research Support, Non-U.S. Gov't | G | TDP2 |
6 | 24665340 | rs3756819 | A | C | rs3756819 | pha003052 | 5.55E-05 | phs000221 | phs000501 | 0.26 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs3756819-C | NA | T | TDP2 | intron |
6 | 27298200 | rs9379976 | T | C | rs9379976 | pha003052 | 9.56E-07 | phs000221 | phs000501 | 0.25 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs9379976-C | NA | T | NA | NA |
6 | 27298279 | rs9379977 | T | C | rs9379977 | pha003052 | 7.90E-07 | phs000221 | phs000501 | 0.25 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs9379977-C | NA | T | NA | NA |
6 | 27298905 | rs721600 | C | T | rs721600 | pha003052 | 3.44E-07 | phs000221 | phs000501 | 0.26 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs721600-T | NA | A | NA | NA |
6 | 27338890 | rs9468076 | C | T | rs9468076 | pha003052 | 3.45E-06 | phs000221 | phs000501 | 0.25 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs9468076-T | NA | T | ZNF204P | intron |
6 | 30093364 | rs10947055 | T | C | rs10947055 | 21348951 | 2.00E-07 | additive, recessive | NA | NA | 851 Old Order Amish individuals | Amish(851) | ALL(851) | EUR(851) | ALL(851) | Cardiac hypertrophy | HPOID:0001639 | Hypertrophic cardiomyopathy | DOID:11984 | hypertrophic cardiomyopathy | D006332 | Cardiomegaly | EFOID:0002503 | cardiac hypertrophy | Heart disease | NA | Research Support, N.I.H., Extramural | T | NA |
6 | 31145920 | rs887464 | C | T | rs887464 | pha003052 | 8.80E-05 | phs000221 | phs000501 | 0.18 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs887464-T | NA | G | PSORS1C3 | nearGene-5 |
6 | 35395618 | rs1053049 | C | T | rs1053049 | pha003052 | 5.55E-05 | phs000221 | phs000501 | 0.22 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs1053049-C | NA | C | PPARD | UTR-3 |
6 | 104432165 | rs4520040 | G | A | rs4520040 | 21348951 | 3.00E-06 | additive | NA | NA | 851 Old Order Amish individuals | Amish(851) | ALL(851) | EUR(851) | ALL(851) | Cardiac hypertrophy | HPOID:0001639 | Hypertrophic cardiomyopathy | DOID:11984 | hypertrophic cardiomyopathy | D006332 | Cardiomegaly | EFOID:0002503 | cardiac hypertrophy | Heart disease | NA | Research Support, N.I.H., Extramural | A | NA |
6 | 109110096 | rs568064 | T | C | rs568064 | pha003052 | 4.40E-05 | phs000221 | phs000501 | 0.19 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs568064-T | NA | G | NA | NA |
6 | 109116491 | rs1268128 | C | A | rs1268128 | pha003052 | 3.51E-05 | phs000221 | phs000501 | 0.19 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs1268128-C | NA | A | NA | NA |
6 | 109240562 | rs13219800 | A | G | rs13219800 | pha003052 | 1.19E-05 | phs000221 | phs000501 | 0.21 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs13219800-G | NA | A | ARMC2 | intron |
6 | 113502071 | rs1883973 | A | G | rs1883973 | pha003052 | 1.22E-05 | phs000221 | phs000501 | 0.4 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs1883973-A | NA | C | NA | NA |
6 | 113503020 | rs1321023 | A | G | rs1321023 | pha003052 | 1.22E-05 | phs000221 | phs000501 | 0.04 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs1321023-A | NA | C | NA | NA |
6 | 154748630 | rs9322464 | C | T | rs9322464 | pha003052 | 3.09E-05 | phs000221 | phs000501 | 0.19 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs9322464-T | NA | C | CNKSR3 | intron |
6 | 154749087 | rs9397717 | G | A | rs9397717 | pha003052 | 1.86E-06 | phs000221 | phs000501 | 0.22 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs9397717-G | NA | A | CNKSR3 | intron |
6 | 154761284 | rs6911312 | C | A | rs6911312 | pha003052 | 6.56E-05 | phs000221 | phs000501 | 0.19 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs6911312-C | NA | A | CNKSR3 | intron |
7 | 5516940 | rs7808325 | C | T | rs7808325 | pha003052 | 3.37E-05 | phs000221 | phs000501 | 0.19 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs7808325-T | NA | C | FBXL18 | UTR-3 |
7 | 5520663 | rs10281893 | G | A | rs10281893 | pha003052 | 3.91E-06 | phs000221 | phs000501 | 0.21 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs10281893-A | NA | G | FBXL18 | UTR-3 |
7 | 5528375 | rs10807949 | C | T | rs10807949 | pha003052 | 5.05E-05 | phs000221 | phs000501 | 0.18 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs10807949-T | NA | C | FBXL18 | intron |
7 | 29343177 | rs3812338 | G | A | rs3812338 | pha003052 | 5.46E-05 | phs000221 | phs000501 | 0.19 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs3812338-A | NA | C | CHN2 | intron |
7 | 45464222 | rs1917716 | C | A | rs1917716 | pha003052 | 8.40E-05 | phs000221 | phs000501 | 0.22 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs1917716-A | NA | C | NA | NA |
7 | 93182557 | rs1000912 | C | T | rs1000912 | pha003052 | 2.45E-05 | phs000221 | phs000501 | 0.19 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs1000912-C | NA | A | CALCR | intron |
7 | 93192036 | rs1548456 | T | C | rs1548456 | pha003052 | 3.77E-05 | phs000221 | phs000501 | 0.19 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs1548456-T | NA | C | CALCR | intron |
7 | 104215832 | rs4400323 | C | T | rs4400323 | pha003052 | 7.57E-05 | phs000221 | phs000501 | 0.21 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs4400323-T | NA | T | LHFPL3 | intron |
7 | 119579473 | rs13234712 | A | G | rs13234712 | pha003052 | 1.25E-05 | phs000221 | phs000501 | 0.21 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs13234712-G | NA | G | NA | NA |
7 | 119583406 | rs10233545 | G | A | rs10233545 | pha003052 | 4.23E-05 | phs000221 | phs000501 | 0.2 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs10233545-A | NA | A | NA | NA |
8 | 11896831 | rs7821214 | T | C | rs7821214 | pha003052 | 3.55E-05 | phs000221 | phs000501 | 0.35 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs7821214-T | NA | C | NA | NA |
8 | 27530475 | rs1036710 | C | T | rs1036710 | pha003052 | 3.25E-05 | phs000221 | phs000501 | 0.4 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs1036710-T | NA | C | SCARA3 | UTR-3 |
8 | 54547981 | rs6473877 | T | C | rs6473877 | pha003052 | 6.91E-05 | phs000221 | phs000501 | 0.19 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs6473877-T | NA | T | NA | NA |
8 | 61003897 | rs6995588 | C | T | rs6995588 | 21348951 | 2.00E-06 | additive, dominant | NA | NA | 851 Old Order Amish individuals | Amish(851) | ALL(851) | EUR(851) | ALL(851) | Cardiac hypertrophy | HPOID:0001639 | Hypertrophic cardiomyopathy | DOID:11984 | hypertrophic cardiomyopathy | D006332 | Cardiomegaly | EFOID:0002503 | cardiac hypertrophy | Heart disease | NA | Research Support, N.I.H., Extramural | C | NA |
8 | 73746989 | rs6472704 | A | G | rs6472704 | pha003052 | 2.00E-05 | phs000221 | phs000501 | 0.22 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs6472704-G | NA | A | KCNB2 | intron |
8 | 119095507 | rs2445904 | C | T | rs2445904 | pha003052 | 4.55E-06 | phs000221 | phs000501 | 0.22 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs2445904-T | NA | T | EXT1 | intron |
8 | 119095747 | rs2468133 | C | T | rs2468133 | pha003052 | 3.73E-06 | phs000221 | phs000501 | 0.22 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs2468133-C | NA | C | EXT1 | intron |
8 | 119106346 | rs2445906 | C | T | rs2445906 | pha003052 | 2.69E-06 | phs000221 | phs000501 | 0.22 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs2445906-C | NA | C | EXT1 | intron |
8 | 136735506 | rs7460819 | C | T | rs7460819 | pha003052 | 5.92E-05 | phs000221 | phs000501 | 0.19 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs7460819-C | NA | T | NA | NA |
8 | 136739516 | rs6981947 | C | T | rs6981947 | pha003052 | 4.67E-05 | phs000221 | phs000501 | 0.19 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs6981947-C | NA | T | NA | NA |
8 | 138805432 | rs6577840 | G | A | rs6577840 | 21828061 | 7.10E-06 | Left ventricular hypertrophy (LVH) assessed by electrocardiogram (ECG) | NA | NA | 398 Korean cases; 8432 Korean controls | Korean(8830) | ALL(8830) | ASN(8830) | ALL(8830) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | NA | Research Support, Non-U.S. Gov't | G | NA |
8 | 138805788 | rs4909705 | T | C | rs4909705 | 21828061 | 3.70E-06 | Left ventricular hypertrophy (LVH) assessed by electrocardiogram (ECG) | NA | NA | 398 Korean cases; 8432 Korean controls | Korean(8830) | ALL(8830) | ASN(8830) | ALL(8830) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | NA | Research Support, Non-U.S. Gov't | T | NA |
8 | 138807660 | rs7825068 | T | C | rs7825068 | 21828061 | 5.00E-06 | Left ventricular hypertrophy (LVH) assessed by electrocardiogram (ECG) | NA | NA | 398 Korean cases; 8432 Korean controls | Korean(8830) | ALL(8830) | ASN(8830) | ALL(8830) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | NA | Research Support, Non-U.S. Gov't | C | NA |
8 | 138811480 | rs7840530 | A | G | rs7840530 | 21828061 | 7.30E-06 | Left ventricular hypertrophy (LVH) assessed by electrocardiogram (ECG) | NA | NA | 398 Korean cases; 8432 Korean controls | Korean(8830) | ALL(8830) | ASN(8830) | ALL(8830) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | NA | Research Support, Non-U.S. Gov't | T | NA |
9 | 20033087 | rs4246835 | A | G | rs4246835 | pha003052 | 8.32E-05 | phs000221 | phs000501 | 0.18 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs4246835-A | NA | G | NA | NA |
9 | 116356516 | rs12341266 | A | G | rs12341266 | 23255317 | 0.000000132 | NA | NA | NA | 174 European ancestry cases; 823 European ancestry controls | European(997) | ALL(997) | EUR(997) | ALL(997) | Hypertrophic cardiomyopathy | HPOID:0001639 | Hypertrophic cardiomyopathy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | NA | Research Support, N.I.H., Extramural | Research Support, Non-U.S. Gov't | G |
10 | 33549468 | rs16934292 | G | A | rs16934292 | pha003052 | 1.84E-05 | phs000221 | phs000501 | 0.34 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs16934292-A | NA | G | NRP1 | intron |
10 | 57416961 | rs1916521 | C | T | rs1916521 | 21348951 | 5.00E-07 | recessive | NA | NA | 851 Old Order Amish individuals | Amish(851) | ALL(851) | EUR(851) | ALL(851) | Cardiac hypertrophy | HPOID:0001639 | Hypertrophic cardiomyopathy | DOID:11984 | hypertrophic cardiomyopathy | D006332 | Cardiomegaly | EFOID:0002503 | cardiac hypertrophy | Heart disease | NA | Research Support, N.I.H., Extramural | G | NA |
10 | 67780727 | rs10822694 | G | A | rs10822694 | pha003052 | 9.91E-05 | phs000221 | phs000501 | 0.22 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs10822694-A | NA | G | CTNNA3 | intron |
10 | 67837498 | rs2394189 | G | A | rs2394189 | pha003052 | 8.17E-05 | phs000221 | phs000501 | 0.19 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs2394189-G | NA | A | CTNNA3 | intron |
10 | 67849839 | rs7916078 | G | A | rs7916078 | pha003052 | 3.41E-05 | phs000221 | phs000501 | 0.19 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs7916078-A | NA | A | CTNNA3 | intron |
10 | 67930295 | rs10996948 | A | G | rs10996948 | pha003052 | 8.22E-05 | phs000221 | phs000501 | 0.24 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs10996948-G | NA | A | CTNNA3 | intron |
10 | 67960463 | rs4746554 | C | T | rs4746554 | pha003052 | 1.83E-05 | phs000221 | phs000501 | 0.21 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs4746554-C | NA | T | CTNNA3 | intron |
10 | 67996275 | rs10762033 | A | G | rs10762033 | pha003052 | 2.62E-05 | phs000221 | phs000501 | 0.2 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs10762033-G | NA | A | CTNNA3 | intron |
10 | 67996290 | rs10762034 | T | C | rs10762034 | pha003052 | 2.62E-05 | phs000221 | phs000501 | 0.2 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs10762034-C | NA | T | CTNNA3 | intron |
10 | 67998370 | rs4745895 | G | A | rs4745895 | pha003052 | 2.53E-05 | phs000221 | phs000501 | 0.21 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs4745895-G | NA | A | CTNNA3 | intron |
10 | 68000700 | rs10996997 | A | G | rs10996997 | pha003052 | 9.54E-05 | phs000221 | phs000501 | 0.22 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs10996997-G | NA | A | CTNNA3 | intron |
10 | 68028720 | rs7912066 | C | T | rs7912066 | pha003052 | 5.89E-05 | phs000221 | phs000501 | 0.18 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs7912066-T | NA | T | CTNNA3 | intron |
10 | 71426938 | rs9783205 | A | C | rs9783205 | pha003052 | 4.24E-05 | phs000221 | phs000501 | 0.23 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs9783205-C | NA | C | NA | NA |
10 | 71427798 | rs2616069 | G | A | rs2616069 | pha003052 | 4.24E-05 | phs000221 | phs000501 | 0.23 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs2616069-G | NA | T | NA | NA |
10 | 71432279 | rs10509316 | T | C | rs10509316 | pha003052 | 6.77E-05 | phs000221 | phs000501 | 0.22 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs10509316-C | NA | G | NA | NA |
10 | 71437979 | rs12761954 | C | T | rs12761954 | pha003052 | 8.53E-05 | phs000221 | phs000501 | 0.22 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs12761954-T | NA | C | NA | NA |
10 | 82699491 | rs1484170 | T | C | rs1484170 | 21348951 | 1.00E-06 | additive | NA | NA | 851 Old Order Amish individuals | Amish(851) | ALL(851) | EUR(851) | ALL(851) | Cardiac hypertrophy | HPOID:0001639 | Hypertrophic cardiomyopathy | DOID:11984 | hypertrophic cardiomyopathy | D006332 | Cardiomegaly | EFOID:0002503 | cardiac hypertrophy | Heart disease | NA | Research Support, N.I.H., Extramural | T | NA |
10 | 105846074 | rs1320448 | A | G | rs1320448 | 21348951 | 2.00E-08 | additive, recessive | NA | NA | 851 Old Order Amish individuals | Amish(851) | ALL(851) | EUR(851) | ALL(851) | Cardiac hypertrophy | HPOID:0001639 | Hypertrophic cardiomyopathy | DOID:11984 | hypertrophic cardiomyopathy | D006332 | Cardiomegaly | EFOID:0002503 | cardiac hypertrophy | Heart disease | NA | Research Support, N.I.H., Extramural | G | COL17A1 |
10 | 113512966 | rs4304698 | C | T | rs4304698 | pha003052 | 1.03E-05 | phs000221 | phs000501 | 0.45 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs4304698-C | NA | T | NA | NA |
10 | 113517330 | rs11195714 | G | A | rs11195714 | pha003052 | 4.16E-05 | phs000221 | phs000501 | 0.4 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs11195714-G | NA | G | NA | NA |
10 | 131928643 | rs12414821 | G | A | rs12414821 | pha003052 | 2.11E-05 | phs000221 | phs000501 | 0.28 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs12414821-A | NA | G | NA | NA |
10 | 131949021 | rs12415867 | C | T | rs12415867 | pha003052 | 8.60E-05 | phs000221 | phs000501 | 0.27 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs12415867-T | NA | T | GLRX3 | intron |
10 | 133316452 | rs7922424 | G | A | rs7922424 | pha003052 | 4.37E-05 | phs000221 | phs000501 | 0.35 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs7922424-A | NA | A | NA | NA |
11 | 557342 | rs936466 | T | C | rs936466 | pha003052 | 2.73E-07 | phs000221 | phs000501 | 0.01 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs936466-T | NA | G | C11orf35 | intron |
11 | 616865 | rs3758650 | G | A | rs3758650 | pha003052 | 6.80E-05 | phs000221 | phs000501 | 0.41 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs3758650-A | NA | G | CDHR5 | UTR-3 |
11 | 2271323 | rs739545 | G | A | rs739545 | pha003052 | 5.32E-05 | phs000221 | phs000501 | 0.19 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs739545-A | NA | C | NA | NA |
11 | 11761070 | rs17446021 | C | T | rs17446021 | 21828061 | 4.90E-06 | Left ventricular hypertrophy (LVH) assessed by electrocardiogram (ECG) | NA | NA | 398 Korean cases; 8432 Korean controls | Korean(8830) | ALL(8830) | ASN(8830) | ALL(8830) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | NA | Research Support, Non-U.S. Gov't | T | NA |
11 | 21017397 | rs2896623 | G | A | rs2896623 | pha003052 | 9.40E-05 | phs000221 | phs000501 | 0.25 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs2896623-A | NA | A | NELL1 | intron |
11 | 21022007 | rs12791900 | G | A | rs12791900 | pha003052 | 4.91E-05 | phs000221 | phs000501 | 0.41 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs12791900-A | NA | G | NELL1 | intron |
11 | 36169869 | rs10768195 | A | G | rs10768195 | pha003052 | 1.05E-05 | phs000221 | phs000501 | 0.19 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs10768195-G | NA | G | LDLRAD3 | intron |
11 | 36173252 | rs955249 | G | A | rs955249 | pha003052 | 2.09E-06 | phs000221 | phs000501 | 0.22 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs955249-G | NA | A | LDLRAD3 | intron |
11 | 36178902 | rs7924470 | C | A | rs7924470 | pha003052 | 7.85E-05 | phs000221 | phs000501 | 0.17 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs7924470-C | NA | C | LDLRAD3 | intron |
11 | 36179252 | rs2133522 | A | G | rs2133522 | pha003052 | 5.61E-05 | phs000221 | phs000501 | 0.27 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs2133522-A | NA | C | LDLRAD3 | intron |
11 | 61557803 | rs102275 | T | C | rs102275 | pha003052 | 8.28E-05 | phs000221 | phs000501 | 0.19 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs102275-C | NA | G | C11orf10 | intron |
11 | 61603510 | rs174576 | C | A | rs174576 | pha003052 | 9.98E-05 | phs000221 | phs000501 | 0.04 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs174576-C | NA | A | FADS2 | intron |
11 | 95270802 | rs4121809 | T | C | rs4121809 | pha003052 | 2.27E-05 | phs000221 | phs000501 | 0.19 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs4121809-C | NA | A | NA | NA |
11 | 103345030 | rs11225822 | A | C | rs11225822 | 21828061 | 1.20E-06 | Left ventricular hypertrophy (LVH) assessed by electrocardiogram (ECG) | NA | NA | 398 Korean cases; 8432 Korean controls | Korean(8830) | ALL(8830) | ASN(8830) | ALL(8830) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | NA | Research Support, Non-U.S. Gov't | A | DYNC2H1 |
11 | 130544872 | rs2951955 | T | G | rs2951955 | pha003052 | 7.03E-05 | phs000221 | phs000501 | 0.25 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs2951955-G | NA | T | C11orf44 | intron |
12 | 24654276 | rs4963768 | G | A | rs4963768 | pha003052 | 3.44E-05 | phs000221 | phs000501 | 0.23 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs4963768-A | NA | A | SOX5 | intron |
12 | 26114019 | rs706521 | G | A | rs706521 | pha003052 | 9.88E-05 | phs000221 | phs000501 | 0.19 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs706521-G | NA | T | RASSF8 | intron |
12 | 26123345 | rs706529 | A | G | rs706529 | pha003052 | 7.80E-05 | phs000221 | phs000501 | 0.19 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs706529-A | NA | C | RASSF8 | intron |
12 | 60797703 | rs10506410 | A | T | rs10506410 | 21348951 | 2.00E-06 | dominant | NA | NA | 851 Old Order Amish individuals | Amish(851) | ALL(851) | EUR(851) | ALL(851) | Cardiac hypertrophy | HPOID:0001639 | Hypertrophic cardiomyopathy | DOID:11984 | hypertrophic cardiomyopathy | D006332 | Cardiomegaly | EFOID:0002503 | cardiac hypertrophy | Heart disease | NA | Research Support, N.I.H., Extramural | A | NA |
12 | 81256898 | rs1882169 | T | C | rs1882169 | pha003052 | 9.85E-05 | phs000221 | phs000501 | 0.19 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs1882169-T | NA | C | LIN7A | intron |
13 | 25629820 | rs9511601 | C | T | rs9511601 | pha003052 | 9.69E-05 | phs000221 | phs000501 | 0.18 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs9511601-T | NA | C | NA | NA |
13 | 34731033 | rs9528685 | T | C | rs9528685 | pha003052 | 3.42E-05 | phs000221 | phs000501 | 0.21 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs9528685-C | NA | T | NA | NA |
13 | 48198716 | rs1575891 | T | C | rs1575891 | 21348951 | 6.00E-06 | additive | NA | NA | 851 Old Order Amish individuals | Amish(851) | ALL(851) | EUR(851) | ALL(851) | Cardiac hypertrophy | HPOID:0001639 | Hypertrophic cardiomyopathy | DOID:11984 | hypertrophic cardiomyopathy | D006332 | Cardiomegaly | EFOID:0002503 | cardiac hypertrophy | Heart disease | NA | Research Support, N.I.H., Extramural | C | NA |
13 | 50080847 | rs2031532 | A | G | rs2031532 | 21348951 | 5.00E-06 | recessive | NA | NA | 851 Old Order Amish individuals | Amish(851) | ALL(851) | EUR(851) | ALL(851) | Cardiac hypertrophy | HPOID:0001639 | Hypertrophic cardiomyopathy | DOID:11984 | hypertrophic cardiomyopathy | D006332 | Cardiomegaly | EFOID:0002503 | cardiac hypertrophy | Heart disease | NA | Research Support, N.I.H., Extramural | G | PHF11 |
13 | 51111464 | rs3118912 | C | T | rs3118912 | pha003052 | 7.39E-05 | phs000221 | phs000501 | 0.21 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs3118912-T | NA | C | NA | NA |
13 | 51116901 | rs3118914 | G | T | rs3118914 | pha003052 | 5.51E-05 | phs000221 | phs000501 | 0.22 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs3118914-T | NA | G | NA | NA |
13 | 51117562 | rs3116605 | T | C | rs3116605 | pha003052 | 7.51E-05 | phs000221 | phs000501 | 0.21 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs3116605-C | NA | T | NA | NA |
14 | 22925352 | rs1882704 | G | A | rs1882704 | pha003052 | 9.09E-05 | phs000221 | phs000501 | 0.19 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs1882704-G | NA | A | NA | NA |
14 | 33074970 | rs1956217 | A | G | rs1956217 | 21828061 | 7.90E-06 | Left ventricular hypertrophy (LVH) assessed by electrocardiogram (ECG) | NA | NA | 398 Korean cases; 8432 Korean controls | Korean(8830) | ALL(8830) | ASN(8830) | ALL(8830) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | NA | Research Support, Non-U.S. Gov't | A | AKAP6 |
15 | 25912339 | rs17636733 | T | C | rs17636733 | 21348951 | 2.00E-07 | recessive | NA | NA | 851 Old Order Amish individuals | Amish(851) | ALL(851) | EUR(851) | ALL(851) | Cardiac hypertrophy | HPOID:0001639 | Hypertrophic cardiomyopathy | DOID:11984 | hypertrophic cardiomyopathy | D006332 | Cardiomegaly | EFOID:0002503 | cardiac hypertrophy | Heart disease | NA | Research Support, N.I.H., Extramural | T | NA |
15 | 37174748 | rs17432433 | A | G | rs17432433 | pha003052 | 4.53E-05 | phs000221 | phs000501 | 0.18 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs17432433-A | NA | A | LOC145845 | intron |
15 | 39315358 | rs12907914 | G | C | rs12907914 | 21348951 | 1.00E-06 | recessive | NA | NA | 851 Old Order Amish individuals | Amish(851) | ALL(851) | EUR(851) | ALL(851) | Cardiac hypertrophy | HPOID:0001639 | Hypertrophic cardiomyopathy | DOID:11984 | hypertrophic cardiomyopathy | D006332 | Cardiomegaly | EFOID:0002503 | cardiac hypertrophy | Heart disease | NA | Research Support, N.I.H., Extramural | G | NA |
15 | 94855550 | rs13329421 | G | T | rs13329421 | pha003052 | 4.33E-05 | phs000221 | phs000501 | 0.27 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs13329421-T | NA | T | MCTP2 | intron |
16 | 9090615 | rs4438302 | T | G | rs4438302 | pha003052 | 1.51E-05 | phs000221 | phs000501 | 0.22 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs4438302-T | NA | T | NA | NA |
16 | 13253956 | rs153091 | G | T | rs153091 | pha003052 | 1.05E-05 | phs000221 | phs000501 | 0.25 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs153091-G | NA | NA | SHISA9 | intron |
16 | 15606987 | rs1125972 | A | G | rs1125972 | pha003052 | 4.85E-05 | phs000221 | phs000501 | 0.34 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs1125972-G | NA | T | C16orf45 | intron |
16 | 78657827 | rs2738571 | G | A | rs2738571 | pha003052 | 1.60E-06 | phs000221 | phs000501 | 0.25 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs2738571-G | NA | G | WWOX | intron |
16 | 81941319 | rs1143689 | C | T | rs1143689 | pha003052 | 6.06E-05 | phs000221 | phs000501 | 0.21 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs1143689-C | NA | C | PLCG2 | cds-synon |
17 | 40154777 | rs4239268 | G | A | rs4239268 | 21828061 | 9.90E-06 | Left ventricular hypertrophy (LVH) assessed by electrocardiogram (ECG) | NA | NA | 398 Korean cases; 8432 Korean controls | Korean(8830) | ALL(8830) | ASN(8830) | ALL(8830) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | NA | Research Support, Non-U.S. Gov't | A | DNAJC7 |
18 | 9637626 | rs17508949 | A | G | rs17508949 | pha003052 | 4.04E-05 | phs000221 | phs000501 | 0.3 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs17508949-G | NA | A | NA | NA |
18 | 34261048 | rs516514 | C | T | rs516514 | 23255317 | 0.000000125 | NA | NA | NA | 174 European ancestry cases; 823 European ancestry controls | European(997) | ALL(997) | EUR(997) | ALL(997) | Hypertrophic cardiomyopathy | HPOID:0001639 | Hypertrophic cardiomyopathy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | NA | Research Support, N.I.H., Extramural | Research Support, Non-U.S. Gov't | T |
18 | 41440151 | rs1460521 | C | T | rs1460521 | pha003052 | 5.91E-05 | phs000221 | phs000501 | 0.18 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs1460521-T | NA | G | NA | NA |
18 | 45319554 | rs2852945 | C | T | rs2852945 | pha003052 | 3.14E-05 | phs000221 | phs000501 | 0.19 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs2852945-C | NA | G | NA | NA |
19 | 39015454 | rs2071090 | T | C | rs2071090 | 21828061 | 3.60E-08 | Left ventricular hypertrophy (LVH) assessed by electrocardiogram (ECG) | NA | NA | 398 Korean cases; 8432 Korean controls | Korean(8830) | ALL(8830) | ASN(8830) | ALL(8830) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | NA | Research Support, Non-U.S. Gov't | C | RYR1 |
19 | 39035068 | rs10500279 | G | C | rs10500279 | 21828061 | 1.00E-08 | Left ventricular hypertrophy (LVH) assessed by electrocardiogram (ECG) | NA | NA | 398 Korean cases; 8432 Korean controls | Korean(8830) | ALL(8830) | ASN(8830) | ALL(8830) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | NA | Research Support, Non-U.S. Gov't | G | RYR1 |
19 | 39048163 | rs2960321 | C | A | rs2960321 | 21828061 | 2.50E-08 | Left ventricular hypertrophy (LVH) assessed by electrocardiogram (ECG) | NA | NA | 398 Korean cases; 8432 Korean controls | Korean(8830) | ALL(8830) | ASN(8830) | ALL(8830) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | NA | Research Support, Non-U.S. Gov't | A | RYR1 |
19 | 52058461 | rs10412859 | C | T | rs10412859 | pha003052 | 2.74E-06 | phs000221 | phs000501 | 0.22 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs10412859-T | NA | C | NA | NA |
19 | 52068727 | rs7257832 | G | T | rs7257832 | pha003052 | 1.23E-05 | phs000221 | phs000501 | 0.2 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs7257832-G | NA | G | NA | NA |
19 | 55760460 | rs12983684 | G | A | rs12983684 | pha003052 | 5.08E-05 | phs000221 | phs000501 | 0.25 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs12983684-A | NA | G | PPP6R1 | intron |
20 | 11174903 | rs2207418 | G | A | rs2207418 | 21348951 | 9.00E-06 | dominant | NA | NA | 851 Old Order Amish individuals | Amish(851) | ALL(851) | EUR(851) | ALL(851) | Cardiac hypertrophy | HPOID:0001639 | Hypertrophic cardiomyopathy | DOID:11984 | hypertrophic cardiomyopathy | D006332 | Cardiomegaly | EFOID:0002503 | cardiac hypertrophy | Heart disease | NA | Research Support, N.I.H., Extramural | T | NA |
20 | 57087712 | rs749210 | G | A | rs749210 | pha003052 | 1.59E-05 | phs000221 | phs000501 | 0.25 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs749210-A | NA | T | APCDD1L | intron |
21 | 22883278 | rs233783 | A | C | rs233783 | pha003052 | 1.36E-05 | phs000221 | phs000501 | 0.32 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs233783-C | NA | T | NCAM2 | intron |
21 | 23035381 | rs2223148 | G | A | rs2223148 | pha003052 | 4.15E-05 | phs000221 | phs000501 | 0.28 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs2223148-G | NA | G | NA | NA |
21 | 23043241 | rs2826940 | G | A | rs2826940 | pha003052 | 4.06E-05 | phs000221 | phs000501 | 0.29 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs2826940-A | NA | G | NA | NA |
21 | 23044990 | rs2826942 | T | C | rs2826942 | pha003052 | 5.83E-05 | phs000221 | phs000501 | 0.28 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs2826942-C | NA | T | NA | NA |
22 | 26641384 | rs17302009 | C | T | rs17302009 | pha003052 | 6.66E-05 | phs000221 | phs000501 | 0.24 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs17302009-T | NA | C | SEZ6L | intron |
22 | 26665807 | rs17394336 | G | A | rs17394336 | pha003052 | 4.49E-05 | phs000221 | phs000501 | 0.29 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs17394336-A | NA | G | SEZ6L | intron |
22 | 27440291 | rs9613353 | T | C | rs9613353 | pha003052 | 9.45E-05 | phs000221 | phs000501 | 0.19 | NA | NA | ALL(0) | ALL(0) | Left ventricular hypertrophy | HPOID:0001712 | Left ventricular hypertrophy | DOID:11984 | hypertrophic cardiomyopathy | NA | NA | NA | NA | Heart disease | rs9613353-C | NA | T | NA | NA |
Mapped by lexical matching(Total Items:0) |
---|
(Waiting for update.) |
Mapped by homologous gene(Total Items:0) |
---|
(Waiting for update.) |
Disease ID | 410 |
---|---|
Disease | hypertrophic cardiomyopathy |
Case | (Waiting for update.) |